Redsense Medical AB (publ) (NGM:REDS)
6.00
+0.02 (0.33%)
At close: Jun 5, 2025
Redsense Medical AB Revenue
Redsense Medical AB had revenue of 4.88M SEK in the quarter ending March 31, 2025, with 181.65% growth. This brings the company's revenue in the last twelve months to 31.92M, up 57.58% year-over-year. In the year 2024, Redsense Medical AB had annual revenue of 28.77M with 12.74% growth.
Revenue (ttm)
31.92M
Revenue Growth
+57.58%
P/S Ratio
2.97
Revenue / Employee
6.38M
Employees
5
Market Cap
94.72M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.77M | 3.25M | 12.74% |
Dec 31, 2023 | 25.52M | 8.76M | 52.32% |
Dec 31, 2022 | 16.75M | 410.00K | 2.51% |
Dec 31, 2021 | 16.34M | -757.98K | -4.43% |
Dec 31, 2020 | 17.10M | 2.87M | 20.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.31B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Camurus AB | 2.04B |
Medicover AB | 23.56B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |